Structural insight into the molecular mechanism of p53-mediated mitochondrial apoptosis

Nat Commun. 2021 Apr 16;12(1):2280. doi: 10.1038/s41467-021-22655-6.

Abstract

The tumor suppressor p53 is mutated in approximately half of all human cancers. p53 can induce apoptosis through mitochondrial membrane permeabilization by interacting with and antagonizing the anti-apoptotic proteins BCL-xL and BCL-2. However, the mechanisms by which p53 induces mitochondrial apoptosis remain elusive. Here, we report a 2.5 Å crystal structure of human p53/BCL-xL complex. In this structure, two p53 molecules interact as a homodimer, and bind one BCL-xL molecule to form a ternary complex with a 2:1 stoichiometry. Mutations at the p53 dimer interface or p53/BCL-xL interface disrupt p53/BCL-xL interaction and p53-mediated apoptosis. Overall, our current findings of the bona fide structure of p53/BCL-xL complex reveal the molecular basis of the interaction between p53 and BCL-xL, and provide insight into p53-mediated mitochondrial apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / genetics*
  • Cell Line, Tumor
  • Crystallography, X-Ray
  • Humans
  • Mitochondria / physiology*
  • Molecular Docking Simulation
  • Mutation
  • Protein Binding / genetics
  • Protein Multimerization / genetics
  • Recombinant Proteins / genetics
  • Recombinant Proteins / isolation & purification
  • Recombinant Proteins / metabolism
  • Recombinant Proteins / ultrastructure
  • Tumor Suppressor Protein p53 / genetics
  • Tumor Suppressor Protein p53 / isolation & purification
  • Tumor Suppressor Protein p53 / metabolism
  • Tumor Suppressor Protein p53 / ultrastructure*
  • bcl-X Protein / genetics
  • bcl-X Protein / isolation & purification
  • bcl-X Protein / metabolism
  • bcl-X Protein / ultrastructure*

Substances

  • BCL2L1 protein, human
  • Recombinant Proteins
  • TP53 protein, human
  • Tumor Suppressor Protein p53
  • bcl-X Protein